Metabolic response as assessed by (18)F‐fluorodeoxyglucose positron emission tomography‐computed tomography does not predict outcome in patients with intermediate‐ or high‐risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee

BACKGROUND: Strategies to optimize management in rhabdomyosarcoma (RMS) include risk stratification to assign therapy aiming to minimize treatment morbidity yet improve outcomes. This analysis evaluated the relationship between complete metabolic response (CMR) as assessed by (18)F‐fluorodeoxyglucos...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrison, Douglas J., Chi, Yueh‐Yun, Tian, Jing, Hingorani, Pooja, Mascarenhas, Leo, McCowage, Geoffrey B., Weigel, Brenda J., Venkatramani, Rajkumar, Wolden, Suzanne L., Yock, Torunn I., Rodeberg, David A., Hayes‐Jordan, Andrea A., Teot, Lisa A., Spunt, Sheri L., Meyer, William H., Hawkins, Douglas S., Shulkin, Barry L., Parisi, Marguerite T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897958/
https://www.ncbi.nlm.nih.gov/pubmed/33340280
http://dx.doi.org/10.1002/cam4.3667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897958/
https://www.ncbi.nlm.nih.gov/pubmed/33340280
http://dx.doi.org/10.1002/cam4.3667

Ejemplares similares